Acasti Pharma SG&A Expense (Quarterly) Analysis

Acasti Pharma Inc (ACST)

3.01 +0.08 (+2.78%) USD | NASDAQ | Apr 26, 10:21

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2008. Upgrade now.

Date	Value
December 31, 2023	1.60M
September 30, 2023	1.631M
June 30, 2023	1.871M
March 31, 2023	2.516M
December 31, 2022	1.775M
September 30, 2022	1.828M
June 30, 2022	2.094M
March 31, 2022	2.077M
December 31, 2021	2.046M
September 30, 2021	2.982M
June 30, 2021	2.676M
March 31, 2021	1.509M
December 31, 2020	1.331M
September 30, 2020	1.453M
June 30, 2020	2.365M
March 31, 2020	2.113M
December 31, 2019	2.234M
September 30, 2019	2.301M
June 30, 2019	1.816M
March 31, 2019	1.722M
December 31, 2018	0.8473M
September 30, 2018	1.014M
June 30, 2018	0.7877M
March 31, 2018	0.9569M
December 31, 2017	0.6879M

Date	Value
September 30, 2017	0.8351M
June 30, 2017	0.6282M
November 30, 2016	0.617M
August 31, 2016	0.6539M
May 31, 2016	0.434M
February 29, 2016	0.302M
November 30, 2015	0.3597M
August 31, 2015	0.3796M
May 31, 2015	0.508M
February 28, 2015	-1.211M
November 30, 2014	1.066M
August 31, 2014	1.522M
May 31, 2014	1.642M
February 28, 2014	-0.3536M
November 30, 2013	1.928M
August 31, 2013	1.753M
May 31, 2013	1.168M
February 28, 2013	0.9658M
November 30, 2012	1.046M
August 31, 2012	1.102M
May 31, 2012	1.037M
February 29, 2012	1.269M
November 30, 2011	0.8235M
August 31, 2011	0.8736M
May 31, 2011	0.6559M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.331M

Minimum

Dec 2020

2.982M

Maximum

Sep 2021

2.012M

Average

2.046M

Median

Dec 2021

SG&A Expense (Quarterly) Benchmarks